139 related articles for article (PubMed ID: 31162264)
1. Incidental Detection of Splenic Hemangioma on 68Ga-PSMA PET/CT.
Sheng K; Le K; Bui C; Mansberg R
Clin Nucl Med; 2019 Oct; 44(10):821-823. PubMed ID: 31162264
[TBL] [Abstract][Full Text] [Related]
2. Splenic Hemangioma as a Potential Pitfall on PSMA-Targeted 18F-DCFPyL PET/CT.
Chaussé G; Laufer J; Abikhzer G; Probst S
Clin Nucl Med; 2019 Mar; 44(3):255-256. PubMed ID: 30589670
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of whole-body MRI and
Sawicki LM; Kirchner J; Buddensieck C; Antke C; Ullrich T; Schimmöller L; Boos J; Schleich C; Schaarschmidt BM; Buchbender C; Heusch P; Rabenalt R; Albers P; Antoch G; Müller HW; Hautzel H
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1542-1550. PubMed ID: 30879122
[TBL] [Abstract][Full Text] [Related]
4. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
Jia G; Dong A; Cheng C; Zuo C
Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Incidental Detection of Synchronous Benign Hepatic and Splenic Hemangiomas on 18 F-PSMA PET/CT.
Alsaleh MH; Alkhars AS; Albensaad M; Alsharif A
Clin Nucl Med; 2024 Jun; 49(6):e298-e300. PubMed ID: 38537220
[TBL] [Abstract][Full Text] [Related]
7. False-Positive Uptake in Splenic Hemangioma on 68Ga-PSMA PET/CT Scan for Late Biochemical Recurrence of Prostate Cancer.
Brazão ÉS; Ribeiro AMB; Lima ENP; da Costa WH; Zequi SC
Clin Nucl Med; 2022 Jan; 47(1):e14-e16. PubMed ID: 34034314
[TBL] [Abstract][Full Text] [Related]
8.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
9. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in
Freitag MT; Radtke JP; Afshar-Oromieh A; Roethke MC; Hadaschik BA; Gleave M; Bonekamp D; Kopka K; Eder M; Heusser T; Kachelriess M; Wieczorek K; Sachpekidis C; Flechsig P; Giesel F; Hohenfellner M; Haberkorn U; Schlemmer HP; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):776-787. PubMed ID: 27988802
[TBL] [Abstract][Full Text] [Related]
11. Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.
De Bari B; Mazzola R; Aiello D; Fersino S; Gregucci F; Alongi P; Nicodemo M; Cavalleri S; Salgarello M; Alongi F
Radiol Med; 2018 Sep; 123(9):719-725. PubMed ID: 29687208
[TBL] [Abstract][Full Text] [Related]
12. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.
Bhardwaj H; Stephens M; Bhatt M; Thomas PA
Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413
[TBL] [Abstract][Full Text] [Related]
13. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
[TBL] [Abstract][Full Text] [Related]
14. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
[TBL] [Abstract][Full Text] [Related]
15.
Calais J; Czernin J; Cao M; Kishan AU; Hegde JV; Shaverdian N; Sandler K; Chu FI; King CR; Steinberg ML; Rauscher I; Schmidt-Hegemann NS; Poeppel T; Hetkamp P; Ceci F; Herrmann K; Fendler WP; Eiber M; Nickols NG
J Nucl Med; 2018 Feb; 59(2):230-237. PubMed ID: 29123013
[TBL] [Abstract][Full Text] [Related]
16. Incidental Detection of Hypothyroidism on 68Ga-PSMA-HBED-CC PET/CT Imaging.
Sood A; Vadi SK; Kumar R; Singh H; Mittal BR
Clin Nucl Med; 2020 Apr; 45(4):e217-e218. PubMed ID: 32108699
[TBL] [Abstract][Full Text] [Related]
17.
Farolfi A; Ceci F; Castellucci P; Graziani T; Siepe G; Lambertini A; Schiavina R; Lodi F; Morganti AG; Fanti S
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):11-19. PubMed ID: 29905907
[TBL] [Abstract][Full Text] [Related]
18. Treatment Outcomes from
Emmett L; van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P
J Nucl Med; 2017 Dec; 58(12):1972-1976. PubMed ID: 28747524
[No Abstract] [Full Text] [Related]
19. Patterns of relapse as determined by
Henkenberens C; Derlin T; Bengel FM; Ross TL; Wester HJ; Hueper K; Kuczyk MA; Christiansen H; von Klot CA
Strahlenther Onkol; 2018 Apr; 194(4):303-310. PubMed ID: 29134231
[TBL] [Abstract][Full Text] [Related]
20. Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT.
Bilgin R; Ergül N; Çermik TF
Clin Nucl Med; 2016 Dec; 41(12):956-958. PubMed ID: 27824323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
